Buffalo

Micron Appoints Robert Swan to its Board of Directors

Retrieved on: 
Monday, March 11, 2024

BOISE, Idaho, March 11, 2024 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU), an industry leader in innovative memory and storage solutions, today announced the appointment of Robert (Bob) Swan to its board of directors.

Key Points: 
  • BOISE, Idaho, March 11, 2024 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU), an industry leader in innovative memory and storage solutions, today announced the appointment of Robert (Bob) Swan to its board of directors.
  • Prior to joining Intel, as CFO of eBay, Swan played a significant role in driving the company’s global expansion strategy.
  • “We are thrilled to welcome Bob to our board and look forward to his contributions to our strategic direction and long-term success.”
    In addition to his new position at Micron, Swan is on the boards of several organizations, including the board of directors for Nike, Inc., Flexport and the board of commissioners of GoTo Group.
  • He previously served on the board of directors for eBay, Applied Materials, Intel and Skype.

InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

Retrieved on: 
Wednesday, March 6, 2024

TEL AVIV, Israel and MIAMI, March 06, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the treatment of carotid artery disease (CAD) and prevention of stroke, today announced financial and operating results for the fourth quarter and full-year ended December 31, 2023.

Key Points: 
  • Fourth Quarter 2023 and Recent Developments:
    Generated record CGuard revenue in the fourth quarter 2023 of $1.76 million, a 71.6% increase over the fourth quarter of 2022.
  • Sold 3,107 CGuard EPS stent systems in the fourth quarter of 2023, as compared to 1,781 in the fourth quarter of 2022, an increase of 74.5%.
  • Financial Results for the Fourth Quarter Ended December 31, 2023
    For the fourth quarter of 2023, total revenue increased 71.6%, to $1,761,000, from $1,026,000 during the fourth quarter of 2022.
  • Total financial income for the fourth quarter of 2023 was $468,000, an increase of $349,000 or 293% compared to $119,000 for the third quarter of 2022.

Healthy Foods Deliver Defense Against Cancer and Heart Disease

Retrieved on: 
Wednesday, February 21, 2024

The vitamins and minerals in "good-for-you" nourishment provide energy for daily living, help the body grow and repair and can prevent diet-related illnesses like cancer and heart disease.

Key Points: 
  • The vitamins and minerals in "good-for-you" nourishment provide energy for daily living, help the body grow and repair and can prevent diet-related illnesses like cancer and heart disease.
  • According to the Centers for Disease Control and Prevention, heart disease is the leading cause of death in the United States, followed by cancer.
  • There are a number of factors that can increase the risk of developing heart disease, including high blood pressure, high cholesterol, obesity and diabetes .
  • Research shows that in addition to inhibiting colon, prostate and breast cancer cell growth, they can also protect against heart disease.

Summit Ridge Group Promotes Four Key Members

Retrieved on: 
Thursday, February 15, 2024

NEW YORK, Feb. 15, 2024 /PRNewswire/ -- Summit Ridge Group ("SRG"), the leading financial and business valuation consulting boutique focused on telecom, media and satellite industries, is delighted to announce today the well-deserved promotions of four of its team members.

Key Points: 
  • NEW YORK, Feb. 15, 2024 /PRNewswire/ -- Summit Ridge Group ("SRG"), the leading financial and business valuation consulting boutique focused on telecom, media and satellite industries, is delighted to announce today the well-deserved promotions of four of its team members.
  • Internally, she serves as Summit Ridge Group's financial controller.
  • Daniel-John Perez is promoted to Vice-President after joining Summit Ridge Group in the summer of 2018 after graduating from the University at Buffalo with a degree in Business Administration, concentrating in Financial Analysis.
  • Since joining SRG, she has played a key role in the C-Band relocation project and the Rip and Replace project.

FRANK CURCI TO RETIRE AS CEO OF NORTHEAST GROCERY, INC.

Retrieved on: 
Monday, January 22, 2024

SCHENECTADY and WILLIAMSVILLE, N.Y. , Jan. 22, 2024 /PRNewswire/ -- As a part of the company's strategic succession plan, Frank Curci, CEO of Northeast Grocery, Inc. (NGI), the parent company of Price Chopper/Market 32 and Tops Friendly Markets, has announced his retirement. Following an internal and external search, John Persons, NGI's chief operating officer, has been named by the NGI Board of Directors to succeed him, effective February 26, 2024.

Key Points: 
  • SCHENECTADY and WILLIAMSVILLE, N.Y. , Jan. 22, 2024 /PRNewswire/ -- As a part of the company's strategic succession plan, Frank Curci, CEO of Northeast Grocery, Inc. (NGI), the parent company of Price Chopper/Market 32 and Tops Friendly Markets, has announced his retirement.
  • He has been instrumental in our merger success to date, providing the necessary leadership over these past few years to position NGI for success.
  • While John's strategic mindset is poised to lead our multifaceted business day to day, he also possesses great vision for our path forward," said Curci.
  • That plan ultimately led to the selection of Persons to succeed Curci.

Eterna Therapeutics Names Sanjeev Luther as President and Chief Executive Officer

Retrieved on: 
Wednesday, December 20, 2023

CAMBRIDGE, Mass., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA ) (“Eterna” or the “Company”), a life science company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines, has appointed Sanjeev Luther as President and Chief Executive Officer and a member of the company's Board of Directors, effective January 1, 2024.

Key Points: 
  • CAMBRIDGE, Mass., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA ) (“Eterna” or the “Company”), a life science company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines, has appointed Sanjeev Luther as President and Chief Executive Officer and a member of the company's Board of Directors, effective January 1, 2024.
  • Mr. Luther will replace Matt Angel, Ph.D., the current President and Chief Executive Officer.
  • Sanjeev has an impressive track record in leadership, strategic planning, and business development across various global organizations in the pharmaceutical and healthcare sectors.
  • At Cornerstone, he also held the roles of Chief Operations Officer and Chief Business Officer.

InspireMD Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of CGuard EPS for the Treatment of Acute Stroke Patients with Tandem Lesions

Retrieved on: 
Monday, November 27, 2023

As a result, there are currently no FDA approved stents for this specific indication.

Key Points: 
  • As a result, there are currently no FDA approved stents for this specific indication.
  • Retrospective analyses from large centers across the globe have suggested the safety and efficacy of stenting in conjunction with intracranial thrombectomy.
  • I am also excited that this brings the carotid disease as it pertains to neurointerventionalists to the forefront.
  • The EFS is expected to enroll 15 patients across three U.S. trial sites and explore the safety and feasibility of using the CGuard EPS carotid stent, with its unique MicroNet™ mesh covering, to treat acute ischemic stroke patients with tandem lesions.

Knott's Foods Welcomes Fourth Generation in Serving Spreads, Dips and Snacks Across the Nation

Retrieved on: 
Friday, December 22, 2023

JACKSON, Tenn., Dec. 22, 2023 /PRNewswire-PRWeb/ -- Knott's Fine Foods, a longstanding family-owned West Tennessee business, has ushered in a new era in its 76-year history, as CEO Josh Knott has welcomed the first member of the fourth generation, his daughter Chloe Knott, to lead sales and marketing. The father-daughter team is actively promoting Knott's products across the nation.

Key Points: 
  • "Having Chloe on board to integrate her ideas into our business strategy and share our adventures will help shape the future of Knott's," Josh said.
  • Since taking on her new role, Chloe has been involved with trade shows and special events across the country.
  • "Our West Tennessee team has been instrumental in helping us grow in serving our dips, spreads and pickled products around the nation from beautiful Henry County," Josh said.
  • Family-owned and operated since 1947, Knott's Foods Inc. began in the kitchen of Cedric and Mildred Knott in Paris, Tennessee.

Columbia University Takes First Place At Eighth Annual Colvin Case Study Challenge

Retrieved on: 
Tuesday, December 19, 2023

COLLEGE PARK, Md., Dec. 19, 2023 /PRNewswire-PRWeb/ -- A mixed-use residential and commercial building located in Downtown Brooklyn won first place at the eighth annual Colvin Case Study Challenge on Saturday, Dec. 9. A team from Columbia University beat semi-finalists from the University of Houston, Clemson University and the University at Buffalo with their case study of One Boerum Place in a juried, live competition at the University of Maryland (UMD).

Key Points: 
  • A mixed-use residential and commercial building located in Downtown Brooklyn won first place at the eighth annual Colvin Case Study Challenge on Saturday, Dec. 9.
  • A team from Columbia University beat semi-finalists from the University of Houston, Clemson University and the University at Buffalo with their case study of One Boerum Place in a juried, live competition at the University of Maryland (UMD).
  • COLLEGE PARK, Md., Dec. 19, 2023 /PRNewswire-PRWeb/ -- A mixed-use residential and commercial building located in Downtown Brooklyn won first place at the eighth annual Colvin Case Study Challenge on Saturday, Dec. 9.
  • A team from Columbia University beat semi-finalists from the University of Houston, Clemson University and the University at Buffalo with their case study of One Boerum Place in a juried, live competition at the University of Maryland (UMD).

Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434

Retrieved on: 
Thursday, November 16, 2023

The poster entitled, “Potent Antioxidant and Mitochondrial-protectant Effects of ATH434, a Novel Inhibitor of α-Synuclein Aggregation with Moderate Iron-binding Affinity,” presents new data indicating that ATH434 can preserve mitochondrial function after oxidative injury and exert direct anti-oxidant activity independent of its iron binding properties.

Key Points: 
  • The poster entitled, “Potent Antioxidant and Mitochondrial-protectant Effects of ATH434, a Novel Inhibitor of α-Synuclein Aggregation with Moderate Iron-binding Affinity,” presents new data indicating that ATH434 can preserve mitochondrial function after oxidative injury and exert direct anti-oxidant activity independent of its iron binding properties.
  • These features were not observed with another iron binding agent approved for treating iron overload that was also investigated.
  • David Stamler, M.D., Chief Executive Officer of Alterity, commented, “These exciting new data underscore the potential of ATH434 as a treatment for neurodegenerative diseases, including Parkinson’s disease and related disorders.
  • We have long known that ATH434 is able to reduce labile iron which, when elevated, can drive oxidative stress.